发布求助
搜索
全部 求助中 待确认 已完结
其它数据库
已完结 HER-3 Overexpression Is Prognostic of Reduced Breast Cancer Survival A Study of 4046 Patients
用户Hk9Gh1 用户Hk9Gh1
2026-09-02
10
下载文件
ACS
已完结 Enantioselective Radical Addition to Ketones through Lewis Acid-Enabled Photoredox Catalysis
用户CxrY8d 用户CxrY8d
2026-09-02
10
下载文件
其它数据库
已完结 Circulating Tumor DNA Dynamics and Clinical Outcomes in Patients with Advanced Colorectal Cancer Treated with Cetuximab-Based Induction and Maintenance Treatment
用户Hk9Gh1 用户Hk9Gh1
2026-09-02
10
下载文件
其它数据库
求助中 Impact of TP53, KEAP1 and STK11 mutations in localized-stage NSCLC: A European thoracic oncology platform lungscape project
用户Hk9Gh1 用户Hk9Gh1
2026-09-02
10
我要应助
其它数据库
已完结 Hitting the Mark — Individualizing Therapy for HER2-Positive Early-Stage Breast Cancer
用户Hk9Gh1 用户Hk9Gh1
2026-09-02
10
下载文件
其它数据库
求助中 Targeting claudins in cancer
用户Hk9Gh1 用户Hk9Gh1
2026-09-02
10
我要应助
其它数据库
已完结 Clinical trial endpoints for metastases-directed therapy in oligometastatic cancer: a review and Delphi consensus on behalf of the EORTC–ESTRO OligoCare consortium
用户Hk9Gh1 用户Hk9Gh1
2026-09-02
10
下载文件
其它数据库
已完结 The antibiotic-immunotherapy interaction in NSCLC: a systematic review and meta-analysis of 54,250 patients across three outcomes
用户Hk9Gh1 用户Hk9Gh1
2026-09-02
10
下载文件
其它数据库
求助中 Bispecific Antibody Ivonescimab Added to Chemotherapy in EGFR-Variant Non–Small Cell Lung Cancer The HARMONi-A Randomized Clinical Trial
用户Hk9Gh1 用户Hk9Gh1
2026-09-02
10
我要应助
其它数据库
求助中 Emerging trends in the global burden of colorectal cancer
用户Hk9Gh1 用户Hk9Gh1
2026-09-02
10
我要应助
其它数据库
求助中 Antibody–drug conjugates in gynaecological cancers: opportunities and challenges
用户Hk9Gh1 用户Hk9Gh1
2026-09-02
10
我要应助
其它数据库
求助中 New standards and new constraints redefine treatment sequencing in platinum-resistant ovarian cancer
用户Hk9Gh1 用户Hk9Gh1
2026-09-02
10
我要应助
其它数据库
求助中 Setidegrasib in Advanced Non–Small-Cell Lung Cancer and Pancreatic Cancer
用户Hk9Gh1 用户Hk9Gh1
2026-09-02
10
我要应助
其它数据库
求助中 Fovinaciclib for First-Line Therapy of Advanced Breast Cancer A Randomized Clinical Tria
用户Hk9Gh1 用户Hk9Gh1
2026-09-02
10
我要应助
其它数据库
求助中 Is Progression-Free Survival 2 Ready for Prime Time in US Food and Drug Administration Regulatory Decision Making?
用户Hk9Gh1 用户Hk9Gh1
2026-09-02
10
我要应助
其它数据库
求助中 Is There Still Room for Monotherapy in EGFR-Mutated Non–Small Cell Lung Cancer?
用户Hk9Gh1 用户Hk9Gh1
2026-09-02
10
我要应助
springer
已完结 Fusarium species and their mycotoxins in infected corn in Italy.
用户F9GHZJ 用户F9GHZJ
2026-09-02
10
下载文件
其它数据库
求助中 Pembrolizumab-Chemotherapy Versus Pembrolizumab in Head and Neck Squamous Cell Carcinoma: A PD-L1 CPS-Stratified Analysis of Updated KEYNOTE-048 Data
用户Hk9Gh1 用户Hk9Gh1
2026-09-02
10
我要应助
其它数据库
求助中 Antibody-drug conjugate design and mechanisms of action for cancer treatment: state of the art and beyond
用户Hk9Gh1 用户Hk9Gh1
2026-09-02
10
我要应助
其它数据库
已完结 Pembrolizumab Monotherapy in Sorafenib-Treated and Treatment-Naïve Advanced Hepatocellular Carcinoma: Long-Term Follow-up of the Open-Label, Phase II KEYNOTE-224 Study
用户Hk9Gh1 用户Hk9Gh1
2026-09-02
10
下载文件